test

Scott Epstein

@Avoro Capital Advisors Llc

Latest period2024 - Q3ReportedManaged Assets$6.858BTotal holdings36
Assets growth rate-8.66%Assets growth rate (2-Q avg)-10.54%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.858B in assets, with a quarterly growth rate of -8.66% and a 2-quarter average growth rate of -10.54%. The portfolio is managed by Scott Epstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
XENEXenon Pharmaceuticals Inc
Recent Activity
3.26%
$223.097M
5.667M shares@ $39.37 avg price
KYMRKymera Therapeutics Inc
Recent Activity
Increased 15.72%
3.11%
$212.985M
4.5M shares@ $47.33 avg price
VERAVera Therapeutics Inc
Recent Activity
2.78%
$190.484M
4.31M shares@ $44.2 avg price
ARWRArrowhead Pharmaceuticals Inc.
Recent Activity
2.52%
$172.178M
8.889M shares@ $19.38 avg price
BMRNBiomarin Pharmaceutical Inc
Recent Activity
Decreased -55.28%
2.09%
$143.252M
2.038M shares@ $70.29 avg price
MLTXMoonlake Immunotherapeutics
Recent Activity
Increased 0.01%
2.04%
$139.668M
2.77M shares@ $50.42 avg price
PCVXVaxcyte Inc
Recent Activity
Increased 104.35%
1.96%
$134.267M
1.175M shares@ $114.27 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
Increased 4.28%
1.61%
$110.119M
2.181M shares@ $50.49 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
Decreased -5.6%
1.32%
$90.174M
11.865M shares@ $7.6 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
1.1%
$74.852M
3.888M shares@ $19.25 avg price